CSTL logo

Castle Biosciences, Inc. (CSTL) CAPEX

annual CAPEX:

$28.33M+$14.71M(+107.96%)
December 31, 2024

Summary

  • As of today (September 1, 2025), CSTL annual capital expenditures is $28.33 million, with the most recent change of +$14.71 million (+107.96%) on December 31, 2024.
  • During the last 3 years, CSTL annual CAPEX has risen by +$24.84 million (+713.26%).
  • CSTL annual CAPEX is now at all-time high.

Performance

CSTL CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCSTLcash flow metrics

quarterly CAPEX:

$9.26M+$4.52M(+95.42%)
June 30, 2025

Summary

  • As of today (September 1, 2025), CSTL quarterly capital expenditures is $9.26 million, with the most recent change of +$4.52 million (+95.42%) on June 30, 2025.
  • Over the past year, CSTL quarterly CAPEX has increased by +$4.03 million (+77.15%).
  • CSTL quarterly CAPEX is now at all-time high.

Performance

CSTL quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCSTLcash flow metrics

TTM CAPEX:

$27.95M+$4.03M(+16.87%)
June 30, 2025

Summary

  • As of today (September 1, 2025), CSTL TTM capital expenditures is $27.95 million, with the most recent change of +$4.03 million (+16.87%) on June 30, 2025.
  • Over the past year, CSTL TTM CAPEX has increased by +$7.32 million (+35.48%).
  • CSTL TTM CAPEX is now -1.33% below its all-time high of $28.33 million, reached on December 31, 2024.

Performance

CSTL TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCSTLcash flow metrics

CSTL CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+108.0%+77.2%+35.5%
3 y3 years+713.3%+559.3%+670.5%
5 y5 years+2923.1%+427.5%+909.3%

CSTL CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+713.3%at high+559.3%-1.3%+670.5%
5 y5-yearat high+2923.1%at high+2204.2%-1.3%+909.3%
alltimeall timeat high>+9999.0%at high>+9999.0%-1.3%>+9999.0%

CSTL CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$9.26M(+95.4%)
$27.95M(+16.9%)
Mar 2025
-
$4.74M(-37.4%)
$23.91M(-15.6%)
Dec 2024
$28.33M(+108.0%)
$7.57M(+18.6%)
$28.33M(+15.4%)
Sep 2024
-
$6.38M(+22.0%)
$24.55M(+19.0%)
Jun 2024
-
$5.23M(-42.9%)
$20.63M(+6.1%)
Mar 2024
-
$9.15M(+141.3%)
$19.43M(+42.7%)
Dec 2023
$13.62M(+141.9%)
$3.79M(+54.5%)
$13.62M(+17.3%)
Sep 2023
-
$2.46M(-39.2%)
$11.62M(+3.7%)
Jun 2023
-
$4.04M(+20.9%)
$11.20M(+30.7%)
Mar 2023
-
$3.34M(+86.8%)
$8.57M(+52.1%)
Dec 2022
$5.63M(+61.7%)
$1.79M(-12.3%)
$5.63M(+18.9%)
Sep 2022
-
$2.04M(+45.1%)
$4.74M(+30.6%)
Jun 2022
-
$1.41M(+249.5%)
$3.63M(+15.7%)
Mar 2022
-
$402.00K(-55.0%)
$3.13M(-10.0%)
Dec 2021
$3.48M
$893.00K(-3.7%)
$3.48M(+9.6%)
DateAnnualQuarterlyTTM
Sep 2021
-
$927.00K(+1.5%)
$3.18M(-23.5%)
Jun 2021
-
$913.00K(+21.7%)
$4.16M(-16.9%)
Mar 2021
-
$750.00K(+27.3%)
$5.00M(+5.3%)
Dec 2020
$4.75M(+407.0%)
$589.00K(-69.1%)
$4.75M(+5.4%)
Sep 2020
-
$1.91M(+8.5%)
$4.51M(+62.8%)
Jun 2020
-
$1.76M(+251.2%)
$2.77M(+132.1%)
Mar 2020
-
$500.00K(+44.1%)
$1.19M(+27.3%)
Dec 2019
$937.00K(+238.3%)
$347.00K(+109.0%)
$937.00K(+57.4%)
Sep 2019
-
$166.00K(-7.8%)
$595.40K(+38.7%)
Jun 2019
-
$180.00K(-26.2%)
$429.40K(+5.9%)
Mar 2019
-
$244.00K(+4418.5%)
$405.40K(+113.4%)
Dec 2018
$277.00K(-44.0%)
$5400.00(-96.5%)
$190.00K(+2.9%)
Jun 2018
-
$156.00K(+445.5%)
$184.60K(+545.5%)
Mar 2018
-
$28.60K
$28.60K
Dec 2017
$494.90K
-
-

FAQ

  • What is Castle Biosciences, Inc. annual capital expenditures?
  • What is the all time high annual CAPEX for Castle Biosciences, Inc.?
  • What is Castle Biosciences, Inc. annual CAPEX year-on-year change?
  • What is Castle Biosciences, Inc. quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Castle Biosciences, Inc.?
  • What is Castle Biosciences, Inc. quarterly CAPEX year-on-year change?
  • What is Castle Biosciences, Inc. TTM capital expenditures?
  • What is the all time high TTM CAPEX for Castle Biosciences, Inc.?
  • What is Castle Biosciences, Inc. TTM CAPEX year-on-year change?

What is Castle Biosciences, Inc. annual capital expenditures?

The current annual CAPEX of CSTL is $28.33M

What is the all time high annual CAPEX for Castle Biosciences, Inc.?

Castle Biosciences, Inc. all-time high annual capital expenditures is $28.33M

What is Castle Biosciences, Inc. annual CAPEX year-on-year change?

Over the past year, CSTL annual capital expenditures has changed by +$14.71M (+107.96%)

What is Castle Biosciences, Inc. quarterly capital expenditures?

The current quarterly CAPEX of CSTL is $9.26M

What is the all time high quarterly CAPEX for Castle Biosciences, Inc.?

Castle Biosciences, Inc. all-time high quarterly capital expenditures is $9.26M

What is Castle Biosciences, Inc. quarterly CAPEX year-on-year change?

Over the past year, CSTL quarterly capital expenditures has changed by +$4.03M (+77.15%)

What is Castle Biosciences, Inc. TTM capital expenditures?

The current TTM CAPEX of CSTL is $27.95M

What is the all time high TTM CAPEX for Castle Biosciences, Inc.?

Castle Biosciences, Inc. all-time high TTM capital expenditures is $28.33M

What is Castle Biosciences, Inc. TTM CAPEX year-on-year change?

Over the past year, CSTL TTM capital expenditures has changed by +$7.32M (+35.48%)
On this page